BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24918442)

  • 1. Future declines of coronary heart disease mortality in England and Wales could counter the burden of population ageing.
    Guzman Castillo M; Gillespie DO; Allen K; Bandosz P; Schmid V; Capewell S; O'Flaherty M
    PLoS One; 2014; 9(6):e99482. PubMed ID: 24918442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline.
    Allender S; Scarborough P; O'Flaherty M; Capewell S
    BMC Public Health; 2008 May; 8():148. PubMed ID: 18452595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying policy options for reducing future coronary heart disease mortality in England: a modelling study.
    Scholes S; Bajekal M; Norman P; O'Flaherty M; Hawkins N; Kivimäki M; Capewell S; Raine R
    PLoS One; 2013; 8(7):e69935. PubMed ID: 23936122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population assessment of future trajectories in coronary heart disease mortality.
    Thorolfsdottir RB; Aspelund T; Capewell S; Critchley J; Gudnason V; Andersen K
    PLoS One; 2014; 9(1):e85800. PubMed ID: 24465713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unequal trends in coronary heart disease mortality by socioeconomic circumstances, England 1982-2006: an analytical study.
    Bajekal M; Scholes S; O'Flaherty M; Raine R; Norman P; Capewell S
    PLoS One; 2013; 8(3):e59608. PubMed ID: 23527228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying options for reducing coronary heart disease mortality by 2020.
    Huffman MD; Lloyd-Jones DM; Ning H; Labarthe DR; Guzman Castillo M; O'Flaherty M; Ford ES; Capewell S
    Circulation; 2013 Jun; 127(25):2477-84. PubMed ID: 23661723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America.
    Capewell S; Ford ES; Croft JB; Critchley JA; Greenlund KJ; Labarthe DR
    Bull World Health Organ; 2010 Feb; 88(2):120-30. PubMed ID: 20428369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic Disparities.
    Pearson-Stuttard J; Guzman-Castillo M; Penalvo JL; Rehm CD; Afshin A; Danaei G; Kypridemos C; Gaziano T; Mozaffarian D; Capewell S; O'Flaherty M
    Circulation; 2016 Mar; 133(10):967-78. PubMed ID: 26846769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults.
    O'Flaherty M; Ford E; Allender S; Scarborough P; Capewell S
    Heart; 2008 Feb; 94(2):178-81. PubMed ID: 17641070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010.
    Cheng J; Zhao D; Zeng Z; Critchley JA; Liu J; Wang W; Sun J; Capewell S
    BMC Public Health; 2009 Jan; 9():30. PubMed ID: 19159492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future trends and inequalities in premature coronary deaths in England: Modelling study.
    Allen K; Gillespie DO; Guzman-Castillo M; Diggle PJ; Capewell S; O'Flaherty M
    Int J Cardiol; 2016 Jan; 203():290-7. PubMed ID: 26520277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.
    Moran A; Zhao D; Gu D; Coxson P; Chen CS; Cheng J; Liu J; He J; Goldman L
    BMC Public Health; 2008 Nov; 8():394. PubMed ID: 19036167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study.
    Sahan C; Sozmen K; Unal B; O'Flaherty M; Critchley J
    BMJ Open; 2016 Jul; 6(7):e011217. PubMed ID: 27388358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study.
    Bajekal M; Scholes S; Love H; Hawkins N; O'Flaherty M; Raine R; Capewell S
    PLoS Med; 2012; 9(6):e1001237. PubMed ID: 22719232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling Coronary Heart Disease Mortality declines in the Republic of Ireland, 1985-2006.
    Kabir Z; Perry IJ; Critchley J; O'Flaherty M; Capewell S; Bennett K
    Int J Cardiol; 2013 Oct; 168(3):2462-7. PubMed ID: 23541608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projections of global mortality and burden of disease from 2002 to 2030.
    Mathers CD; Loncar D
    PLoS Med; 2006 Nov; 3(11):e442. PubMed ID: 17132052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary mortality declines in the U.S. between 1980 and 2000 quantifying the contributions from primary and secondary prevention.
    Young F; Capewell S; Ford ES; Critchley JA
    Am J Prev Med; 2010 Sep; 39(3):228-34. PubMed ID: 20709254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality.
    Unal B; Critchley JA; Capewell S
    J Clin Epidemiol; 2005 Jul; 58(7):733-40. PubMed ID: 15939226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.